Related Experiment Video

Updated: Mar 23, 2026

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
14:32

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Published on: February 27, 2016

8.7K

Using mitochondrial sirtuins as drug targets: disease implications and available compounds

Melanie Gertz1,2, Clemens Steegborn3

  • 1Department of Biochemistry, University of Bayreuth, Universitätsstr. 30, 95447, Bayreuth, Germany.

Cellular and Molecular Life Sciences : CMLS
|March 24, 2016
PubMed

Insights

Mitochondrial sirtuins (Sirt3-5) are key regulators of cellular metabolism and aging. This review highlights their roles in disease and discusses small molecules for therapeutic development.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Gerontology

Background:

  • Sirtuins are NAD(+)-dependent protein lysine deacylases crucial for metabolism, stress response, and aging.
  • Mammalian sirtuins (Sirt1-7) regulate diverse cellular processes.
  • Recent focus on mitochondrial sirtuins (Sirt3-5) has spurred therapeutic research.

Purpose of the Study:

  • To review the role of sirtuins, particularly mitochondrial isoforms, in regulating mitochondrial function.
  • To examine the contribution of mitochondrial sirtuins to disease pathologies.
  • To summarize available compounds for modulating mitochondrial sirtuin activity and discuss future drug development.

Main Methods:

  • Literature review of sirtuin research, focusing on mitochondrial isoforms.
  • Analysis of studies on sirtuin involvement in metabolic and aging-related diseases.
  • Compilation of data on small molecule modulators of sirtuin activity.

Main Results:

  • Mitochondrial sirtuins (Sirt3-5) play critical roles in mitochondrial homeostasis and cellular health.
  • Dysregulation of these sirtuins is implicated in various disease states.
  • Several compounds targeting mitochondrial sirtuins show promise for therapeutic intervention.

Conclusions:

  • Mitochondrial sirtuins represent significant therapeutic targets for metabolic and aging-related diseases.
  • Ongoing research and drug development are advancing the potential of small molecule modulators.
  • Further improvements in compound design are crucial for effective therapeutic strategies.
Keywords:
ActivatorDeacylaseDrug developmentInhibitorMetabolic regulationSirt3Sirt4Sirt5

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.9K
Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides08:39

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides

Published on: September 16, 2020

8.6K

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
66
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.2K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.2K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
18.5K